LXRbeta is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice
If enough Part D plans opt-in, this model will become the standard beginning January 2027
Gastroenterology 168(1):184185 Singh S, Chandan S, Dahiya DS, Aswath G, Ramai D, Maida M, Anderloni A, Muscatiello N, Facciorusso A (2024) Impact of GLP-1 receptor agonists in gastrointestinal endoscopy: an updated review
Semaglutide only activates the GLP-1 receptor, while tirzepatide activates both GLP-1 and GIP receptors
The main reasons include gastrointestinal side effects (e.g., nausea, vomiting), high costs , and a preference for oral medication over injections
Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinsons disease